» Articles » PMID: 26220456

Biological Perspectives: Anti-NMDA Receptor Encephalitis

Overview
Date 2015 Jul 30
PMID 26220456
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This article explores the recently recognized anti-NMDA receptor encephalitis, which may produce psychiatric symptoms.

Conclusions: Historically, some patients presenting for psychiatric care may have actually been suffering from anti-NMDA encephalitis; thus, awareness of this disorder may facilitate appropriate treatment.

Treatment Implications: Early diagnosis and aggressive treatment promote better outcomes. First-line treatment includes immunotherapy.

Citing Articles

Contribution of cerebrospinal fluid antibody titers and sex to acute cerebral blood flow in patients with anti-NMDAR autoimmune encephalitis.

Miao A, Wang K Front Immunol. 2024; 15:1299898.

PMID: 38495877 PMC: 10940436. DOI: 10.3389/fimmu.2024.1299898.


Hemiataxia: A Novel Presentation of Anti-NMDA Receptor Antibody Mediated Encephalitis in an Adolescent.

Phillips G, Jones G, Callaghan M, DiFazio M Case Rep Psychiatry. 2018; 2017:1310465.

PMID: 29333310 PMC: 5733199. DOI: 10.1155/2017/1310465.


Chronic Neuropsychological Sequelae in a Patient with Nontumorous Anti-NMDA-Receptor Encephalitis.

Han D, Koehl L, Patel A, Zhou Z, Phillips S, Kapoor S Case Rep Neurol Med. 2017; 2017:5675732.

PMID: 28503332 PMC: 5414487. DOI: 10.1155/2017/5675732.


Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies.

Chen D, Gallagher S, Monson N, Herbst R, Wang Y J Clin Med. 2016; 5(12).

PMID: 27886126 PMC: 5184780. DOI: 10.3390/jcm5120107.